The Valens Posts C$12.8M Loss in Q3

The Valens (VLNS) posted a rise in sales in the third quarter of 2021, but a wider loss than in the third quarter of 2020. The British Columbia-based company produces medical and recreational cannabis products.
Net revenues came in at C$21 million in the…

Click here to view the original article.